Publication: Cox and mesothelioma: an overview
Authors
Cardillo, I. ; Spugnini, E.P. ; Verdina, A. ; Galati, R. ; Citro, G. ; Baldi, A.
item.page.secondaryauthor
item.page.director
Publisher
Murcia : F. Hernández
publication.page.editor
publication.page.department
DOI
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Cyclooxygenases catalyze the rate limiting
step in the production of prostanoids. Accumulating data
demonstrate that overexpression of these enzymes, and
in particular of cyclooxygenases-2, promotes multiple
events involved in tumorigenesis; in addition, numerous
studies show that inhibition of cyclooxygenases-2 can
delay or prevent certain forms of cancer.
Malignant mesothelioma is a lethal pleural,
peritoneal and pericardial neoplasia that actually lacks
valid therapies and in which cyclooxygenases-2 is
recognized as an important adverse prognostic factor.
Hence, there is an increasing interest in the development
of new treatments based on cyclooxygenases-2
inhibitors, to prolong survival and even potentially cure
this neoplasia.
publication.page.subject
Citation
item.page.embargo
Ir a Estadísticas
Sin licencia Creative Commons.